Are survival and mortality rates associated with recruitment to clinical trials in teenage and young adult patients with acute lymphoblastic leukaemia? A retrospective observational analysis in England.

BMJ Open · 2017 · PMC5639992 · PMID 28982824

Europe PMC DOI

hedged sentences

0.3930

closest p · 7.9× alpha

0.3930

boldest claim

The sentences

did not reach statistical significancep=0.393not close (p > 0.1)

The results for 2008–2010 (after closure of UKALLXII) are similar to those for the whole study period: 20–24 year olds in the trial had a 2-year survival 10.2% better than those not in the trial, but this did not reach statistical significance p=0.393.

also in 111,027 other papers

highly significantno p-value reported

The difference in survival was highly significant, with a 17.9% superior survival at 2 years in trial patients compared with non-trial patients.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.